These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 23264901)

  • 1. Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent "NoGlow" Mice.
    Trotter TN; Wilson A; McBane J; Dagotto CE; Yang XY; Wei JP; Lei G; Thrash H; Snyder JC; Lyerly HK; Hartman ZC
    Cancer Res Commun; 2024 Apr; 4(4):1050-1062. PubMed ID: 38592453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines for prostate cancer.
    Zahm CD; Colluru VT; McNeel DG
    Pharmacol Ther; 2017 Jun; 174():27-42. PubMed ID: 28185916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccination for prostate cancer: key concepts and considerations.
    Cole G; McCaffrey J; Ali AA; McCarthy HO
    Cancer Nanotechnol; 2015; 6(1):2. PubMed ID: 26161151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
    NoeDominguez-Romero A; Zamora-Alvarado R; Servín-Blanco R; Pérez-Hernández EG; Castrillon-Rivera LE; Munguia ME; Acero G; Govezensky T; Gevorkian G; Manoutcharian K
    Hum Vaccin Immunother; 2014; 10(11):3201-13. PubMed ID: 25483665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.
    Becker JT; McNeel DG
    J Immunother Cancer; 2013; 1():2. PubMed ID: 24764533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
    Smith HA; Rekoske BT; McNeel DG
    Vaccine; 2014 Mar; 32(15):1707-15. PubMed ID: 24492013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical development of DNA vaccines for prostate cancer.
    Colluru VT; Johnson LE; Olson BM; McNeel DG
    Urol Oncol; 2016 Apr; 34(4):193-204. PubMed ID: 24332642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments.
    Johnson LE; Becker JT; Dubovsky JA; Olson BM; McNeel DG
    Chin Clin Oncol; 2013 Mar; 2(1):. PubMed ID: 24324949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial Watch: Anticancer radioimmunotherapy.
    Vacchelli E; Vitale I; Tartour E; Eggermont A; Sautès-Fridman C; Galon J; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2013 Sep; 2(9):e25595. PubMed ID: 24319634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.
    Becker JT; Olson BM; Johnson LE; Davies JG; Dunphy EJ; McNeel DG
    J Immunother; 2010; 33(6):639-47. PubMed ID: 20551832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
    Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
    Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response.
    Johnson LE; Frye TP; McNeel DG
    Oncoimmunology; 2012 Dec; 1(9):1546-1556. PubMed ID: 23264901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.
    Johnson LE; Frye TP; Chinnasamy N; Chinnasamy D; McNeel DG
    Cancer Immunol Immunother; 2007 Jun; 56(6):885-95. PubMed ID: 17102977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
    Johnson LE; McNeel DG
    Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.